Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The Citicoline Brain Injury Treatment (COBRIT) is a randomized, double-blind, placebo
controlled, multi-center trial of the effects of 90 days of citicoline on functional outcome
in patients with complicated mild, moderate and severe traumatic brain injury.
Phase:
Phase 3
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)